These scRNA-seq profiles were later compared to multiple tumor types (skin melanoma, lung, colorectal, and breast cancer) and helped in analyzing the state of the immune cells in them (for example, activated CD8+ but not CD4+ T cells in the tumor setting) [27,28,29,30,31,32]. Here, CD8A is linked to cutaneous melanoma.